Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from GTBIF

The 3 Best Cannabis Stocks to Buy for 2026

These three cannabis stocks mix regulatory optionality, steady operators, and biotech risk as investors position for 2026 reform tailwinds.

2 Cannabis Stocks I Would Flat-Out Avoid In 2024, and One I Would Buy

2 Cannabis Stocks I Would Flat-Out Avoid In 2024, and One I Would Buy

The cannabis industry is expanding rapidly, but only a few cannabis companies can be winners.

2 'Strong Buy' Cannabis Stocks to Consider Instead of Canopy Growth

2 'Strong Buy' Cannabis Stocks to Consider Instead of Canopy Growth

As the cannabis industry is poised for growth in 2024, top-rated Green Thumb Industries and Verano Holdings have emerged as attractive alternatives to struggling Canopy Growth. Both stocks have significant upside potential, and are making strategic moves that position them well in the evolving market.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Pharma Stocks Poised for Big Returns This Summer

The pharmaceutical industry is expected to grow rapidly due to the ever-rising healthcare needs and the incorporation of cutting-edge technologies into drug manufacturing. Hence, pharma stocks Eli Lilly (LLY), Green Thumb Industries (GTBIF), and Supernus Pharmaceuticals (SUPN) might be worth buying for returns this summer. Read more….

3 Pharma Stocks Primed for May Investment Opportunities

The pharma industry is poised for tremendous growth driven by surging healthcare needs, the introduction of groundbreaking medications, and relentless technological innovation. Hence, quality pharma stocks Collegium Pharmaceutical (COLL), Green Thumb Industries (GTBIF), and Bristol-Myers Squibb (BMY) emerge as prime investment options this month. Read more….

3 Cannabis Stocks With More Upside Potential Than Canopy Growth

Three lesser-known cannabis companies are quietly making moves that could position them as more attractive investment opportunities than the headline-grabbing Canopy Growth.

2 Cannabis Stocks Under $20 That Could Soar, According to Analysts

As more states approve recreational use and governors push the White House to reschedule cannabis, these two low-priced weed stocks stand out as top analyst picks that could blaze a trail higher in 2024.

inkl

Read news from The Economist, FT, and more,
with one subscription

5 Small-Cap Stocks Wall Street Thinks Could Double

5 Small-Cap Stocks Wall Street Thinks Could Double

Market volatility is rife amid the Fed’s aggressive rate hikes and looming recession fears. However, despite the market fluctuations, Wall Street analysts expect quality small-cap stocks, Schrödinger (SDGR), First Advantage Corporation (FA), Green Thumb (GTBIF), Revolve Group (RVLV), and InMode (INMD) could double in the near term. Read on….

Green Thumb Industries Reports 8th Consecutive Quarter Of Positive Cash Flow, Q4 Revenue Up 37% YoY

Green Thumb Industries Reports 8th Consecutive Quarter Of Positive Cash Flow, Q4 Revenue Up 37% YoY

Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), reported its financial results for the fourth quarter and full year ended December 31, 2021.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

the White House

Medical Pharmaceuticals

BristolMyers Squibb Company

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

406,865 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play